Skip to main content

Table 1 Clinical and demographic characteristics of the study participants

From: Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to gene XPERT MTB/RIF ultra for the diagnosis of pulmonary tuberculosis in Uganda

Parameter (N = 250)

n (%)

Gender

 

Male

141(56.4)

Female

108 (43.2)

Missing

1(0.4)

Age Category (years)

 

Median age (IQR)

32.5(30–35)

18–24

43 (17.2)

25–44

168 (67.2)

45–69

34 (13.6)

> 60

5 (2.0)

TB Symptoms

 

Cough

248 (99.2)

Fever

137 (54.8)

Weight loss

143 (57.2)

Night sweats

128(51.2)

Chest pain

126 (50.4)

Previously diagnosed

50 (20.0)

HIV status (246)

 

Positive

109 (43.6)

On ART

79 ( 31.6)

History of smoking (249)

 

Never smoked

177 (71.1)

Ever smoked

72 (28.9)

Current smoker

31 (43.1)

Stopped smoking

41 (56.9)

  1. ART= Antiretroviral Therapy, TB= Tuberculosis, IQR− Interquartile Range, %= percentage